Sundrug Statistics
Total Valuation
Sundrug has a market cap or net worth of JPY 516.29 billion. The enterprise value is 490.00 billion.
Market Cap | 516.29B |
Enterprise Value | 490.00B |
Important Dates
The last earnings date was Thursday, May 15, 2025.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Sundrug has 116.97 million shares outstanding. The number of shares has increased by 0.02% in one year.
Current Share Class | 116.97M |
Shares Outstanding | 116.97M |
Shares Change (YoY) | +0.02% |
Shares Change (QoQ) | -0.00% |
Owned by Insiders (%) | 4.59% |
Owned by Institutions (%) | 27.87% |
Float | 67.02M |
Valuation Ratios
The trailing PE ratio is 16.79 and the forward PE ratio is 15.68. Sundrug's PEG ratio is 2.96.
PE Ratio | 16.79 |
Forward PE | 15.68 |
PS Ratio | 0.64 |
PB Ratio | 1.91 |
P/TBV Ratio | 1.98 |
P/FCF Ratio | 66.94 |
P/OCF Ratio | 12.54 |
PEG Ratio | 2.96 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.14, with an EV/FCF ratio of 63.53.
EV / Earnings | 15.94 |
EV / Sales | 0.61 |
EV / EBITDA | 8.14 |
EV / EBIT | 11.41 |
EV / FCF | 63.53 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.14.
Current Ratio | 1.69 |
Quick Ratio | 0.88 |
Debt / Equity | 0.14 |
Debt / EBITDA | 0.63 |
Debt / FCF | 5.01 |
Interest Coverage | 271.35 |
Financial Efficiency
Return on equity (ROE) is 11.76% and return on invested capital (ROIC) is 9.33%.
Return on Equity (ROE) | 11.76% |
Return on Assets (ROA) | 6.44% |
Return on Invested Capital (ROIC) | 9.33% |
Return on Capital Employed (ROCE) | 14.10% |
Revenue Per Employee | 120.36M |
Profits Per Employee | 4.62M |
Employee Count | 6,662 |
Asset Turnover | 1.86 |
Inventory Turnover | 6.29 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.75% in the last 52 weeks. The beta is 0.22, so Sundrug's price volatility has been lower than the market average.
Beta (5Y) | 0.22 |
52-Week Price Change | +11.75% |
50-Day Moving Average | 4,526.36 |
200-Day Moving Average | 4,155.14 |
Relative Strength Index (RSI) | 39.03 |
Average Volume (20 Days) | 453,890 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sundrug had revenue of JPY 801.81 billion and earned 30.75 billion in profits. Earnings per share was 262.90.
Revenue | 801.81B |
Gross Profit | 204.09B |
Operating Income | 44.50B |
Pretax Income | 43.57B |
Net Income | 30.75B |
EBITDA | 61.78B |
EBIT | 44.50B |
Earnings Per Share (EPS) | 262.90 |
Balance Sheet
The company has 64.96 billion in cash and 38.67 billion in debt, giving a net cash position of 26.29 billion or 224.76 per share.
Cash & Cash Equivalents | 64.96B |
Total Debt | 38.67B |
Net Cash | 26.29B |
Net Cash Per Share | 224.76 |
Equity (Book Value) | 269.71B |
Book Value Per Share | 2,305.88 |
Working Capital | 88.27B |
Cash Flow
In the last 12 months, operating cash flow was 41.16 billion and capital expenditures -33.45 billion, giving a free cash flow of 7.71 billion.
Operating Cash Flow | 41.16B |
Capital Expenditures | -33.45B |
Free Cash Flow | 7.71B |
FCF Per Share | 65.94 |
Margins
Gross margin is 25.45%, with operating and profit margins of 5.55% and 3.84%.
Gross Margin | 25.45% |
Operating Margin | 5.55% |
Pretax Margin | 5.43% |
Profit Margin | 3.84% |
EBITDA Margin | 7.71% |
EBIT Margin | 5.55% |
FCF Margin | 0.96% |
Dividends & Yields
This stock pays an annual dividend of 131.00, which amounts to a dividend yield of 2.95%.
Dividend Per Share | 131.00 |
Dividend Yield | 2.95% |
Dividend Growth (YoY) | 14.04% |
Years of Dividend Growth | 6 |
Payout Ratio | 46.39% |
Buyback Yield | -0.02% |
Shareholder Yield | 2.93% |
Earnings Yield | 5.96% |
FCF Yield | 1.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on March 29, 2017. It was a forward split with a ratio of 2.
Last Split Date | Mar 29, 2017 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Sundrug has an Altman Z-Score of 4.85.
Altman Z-Score | 4.85 |
Piotroski F-Score | n/a |